Sentri7 helps hospitals continuously improve the appropriate use of antibiotics by arming clinicians with information to prevent harm while minimizing drug costs.
Clinically trusted
Quick access to the latest evidence-based ASP guidance.
Access an extensive content library designed for clinicians to continually align with the CDC’s Core Elements of an effective ASP. Optimize clinical care by identifying patients that need attention and alerting clinicians for interventions. Sentri7 saves time by delivering the latest guidance, which is continuously updated to reflect new regulations, science and clinical recommendations. To minimize care variation, concise evidence-based clinical recommendations accompany each rule for qualifying patients.
Empowering
Designed by ASP experts. Controlled by you.
Effectively monitor antimicrobial use to comply with your hospital’s policies. Sentri7 prioritizes patients in real-time by severity, acuity and therapeutic area—delivering trusted alerts and evidence-based guidance to improve care. Tailored workflows drive standardization and enhance productivity. Teams easily document actions to improve continuity across shifts and settings. One click to push key intervention notes to the EHR for enhanced communication. Easily extend programs across facilities and adopt new rules within minutes—without the need for IT or vendor support.
Actionable insights
Transform data into insight to reduce antimicrobial resistance and costs.
Showcase your pharmacy team's impact on antimicrobial utilization with Sentri7’s dedicated Antimicrobial Stewardship dashboard. Transform data into actionable facility or system-level insights to track clinician adherence to ASP policies and procedures, and facilitate feedback to improve performance. Use data visualization tools for views of intervention activity by medication, class, prescriber and days of therapy. Calculate and compare your performance and antimicrobial use to your peers’ Standardized Antimicrobial Administration Ratio data. Easily see the AU cumulative attributable difference (AU-CAD) inside our Analytics dashboard to help you implement the CDC TAS framework for quality improvement.
Are you ready for AUR Reporting?
CMS has incorporated Antimicrobial Use and Resistance (AUR) reporting to National Health and Safety Network (NHSN) as a required element under the Public Health reporting category within Promoting Interoperability Program beginning in 2024. Talk to your Quality leader about the AUR reporting requirement to determine how to avoid penalties for non-reporting.
To qualify for the Promoting Interoperability program credit, AUR reports must be submitted to the NHSN by a vendor—like Sentri7® Pharmacy AMS—certified for AUR reporting by the ONC and listed on the Certified Health IT Product List (CHPL).
This evidence-based, out-of-the-box solution helps you monitor patients in real-time, optimize antimicrobial therapies, and analyze performance in key areas:
Use Sentri7® and its turnkey SoleSource platform to inform continuous improvement, streamline adoption of programs, policies, and procedures – and increase the impact of your pharmacy programs across facilities.
